These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 27174644)

  • 41. CSF1R Inhibition Reduces Microglia Proliferation, Promotes Tissue Preservation and Improves Motor Recovery After Spinal Cord Injury.
    Gerber YN; Saint-Martin GP; Bringuier CM; Bartolami S; Goze-Bac C; Noristani HN; Perrin FE
    Front Cell Neurosci; 2018; 12():368. PubMed ID: 30386212
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dismutase-competent SOD1 mutant accumulation in myelinating Schwann cells is not detrimental to normal or transgenic ALS model mice.
    Turner BJ; Ackerley S; Davies KE; Talbot K
    Hum Mol Genet; 2010 Mar; 19(5):815-24. PubMed ID: 20008901
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Microglial keratan sulfate epitope elicits in central nervous tissues of transgenic model mice and patients with amyotrophic lateral sclerosis.
    Foyez T; Takeda-Uchimura Y; Ishigaki S; Narentuya ; Zhang Z; Sobue G; Kadomatsu K; Uchimura K
    Am J Pathol; 2015 Nov; 185(11):3053-65. PubMed ID: 26362733
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of metal concentrations in the SOD1
    Enge TG; Ecroyd H; Jolley DF; Yerbury JJ; Kalmar B; Dosseto A
    Mol Cell Neurosci; 2018 Apr; 88():319-329. PubMed ID: 29524628
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Olesoxime delays muscle denervation, astrogliosis, microglial activation and motoneuron death in an ALS mouse model.
    Sunyach C; Michaud M; Arnoux T; Bernard-Marissal N; Aebischer J; Latyszenok V; Gouarné C; Raoul C; Pruss RM; Bordet T; Pettmann B
    Neuropharmacology; 2012 Jun; 62(7):2346-52. PubMed ID: 22369784
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS.
    Li W; Brakefield D; Pan Y; Hunter D; Myckatyn TM; Parsadanian A
    Exp Neurol; 2007 Feb; 203(2):457-71. PubMed ID: 17034790
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Schwann cells orchestrate peripheral nerve inflammation through the expression of CSF1, IL-34, and SCF in amyotrophic lateral sclerosis.
    Trias E; Kovacs M; King PH; Si Y; Kwon Y; Varela V; Ibarburu S; Moura IC; Hermine O; Beckman JS; Barbeito L
    Glia; 2020 Jun; 68(6):1165-1181. PubMed ID: 31859421
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serial in vivo imaging of transplanted allogeneic neural stem cell survival in a mouse model of amyotrophic lateral sclerosis.
    Srivastava AK; Gross SK; Almad AA; Bulte CA; Maragakis NJ; Bulte JWM
    Exp Neurol; 2017 Mar; 289():96-102. PubMed ID: 28038988
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Triggering Receptor Expressed on Myeloid Cells-2 (TREM2) Interacts With Colony-Stimulating Factor 1 Receptor (CSF1R) but Is Not Necessary for CSF1/CSF1R-Mediated Microglial Survival.
    Cheng B; Li X; Dai K; Duan S; Rong Z; Chen Y; Lü L; Liu Z; Huang X; Xu H; Zhang YW; Zheng H
    Front Immunol; 2021; 12():633796. PubMed ID: 33841415
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Elevated α5 integrin expression on myeloid cells in motor areas in amyotrophic lateral sclerosis is a therapeutic target.
    Chiot A; Roemer SF; Ryner L; Bogachuk A; Emberley K; Brownell D; Jimenez GA; Leviten M; Woltjer R; Dickson DW; Steinman L; Ajami B
    Proc Natl Acad Sci U S A; 2023 Aug; 120(32):e2306731120. PubMed ID: 37523555
    [TBL] [Abstract][Full Text] [Related]  

  • 51. GAB(A) receptors present higher affinity and modified subunit composition in spinal motor neurons from a genetic model of amyotrophic lateral sclerosis.
    Carunchio I; Mollinari C; Pieri M; Merlo D; Zona C
    Eur J Neurosci; 2008 Oct; 28(7):1275-85. PubMed ID: 18973555
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapeutic effects of hirsutella sinensis on the disease onset and progression of amyotrophic lateral sclerosis in SOD1
    Shang HY; Zhang JJ; Fu ZF; Liu YF; Li S; Chen S; Le WD
    CNS Neurosci Ther; 2020 Jan; 26(1):90-100. PubMed ID: 31318169
    [TBL] [Abstract][Full Text] [Related]  

  • 53. GLT1 overexpression in SOD1(G93A) mouse cervical spinal cord does not preserve diaphragm function or extend disease.
    Li K; Hala TJ; Seetharam S; Poulsen DJ; Wright MC; Lepore AC
    Neurobiol Dis; 2015 Jun; 78():12-23. PubMed ID: 25818008
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immune response in peripheral axons delays disease progression in SOD1
    Nardo G; Trolese MC; de Vito G; Cecchi R; Riva N; Dina G; Heath PR; Quattrini A; Shaw PJ; Piazza V; Bendotti C
    J Neuroinflammation; 2016 Oct; 13(1):261. PubMed ID: 27717377
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins.
    Deora V; Lee JD; Albornoz EA; McAlary L; Jagaraj CJ; Robertson AAB; Atkin JD; Cooper MA; Schroder K; Yerbury JJ; Gordon R; Woodruff TM
    Glia; 2020 Feb; 68(2):407-421. PubMed ID: 31596526
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Progressive impairment of CaV1.1 function in the skeletal muscle of mice expressing a mutant type 1 Cu/Zn superoxide dismutase (G93A) linked to amyotrophic lateral sclerosis.
    Beqollari D; Romberg CF; Dobrowolny G; Martini M; Voss AA; Musarò A; Bannister RA
    Skelet Muscle; 2016; 6():24. PubMed ID: 27340545
    [TBL] [Abstract][Full Text] [Related]  

  • 57. "Preconditioning" with latrepirdine, an adenosine 5'-monophosphate-activated protein kinase activator, delays amyotrophic lateral sclerosis progression in SOD1(G93A) mice.
    Coughlan KS; Mitchem MR; Hogg MC; Prehn JH
    Neurobiol Aging; 2015 Feb; 36(2):1140-50. PubMed ID: 25443289
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Extracellular mutant SOD1 induces microglial-mediated motoneuron injury.
    Zhao W; Beers DR; Henkel JS; Zhang W; Urushitani M; Julien JP; Appel SH
    Glia; 2010 Jan; 58(2):231-43. PubMed ID: 19672969
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Origin and distribution of bone marrow-derived cells in the central nervous system in a mouse model of amyotrophic lateral sclerosis.
    Solomon JN; Lewis CA; Ajami B; Corbel SY; Rossi FM; Krieger C
    Glia; 2006 May; 53(7):744-53. PubMed ID: 16518833
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Novel HGF/SF Receptor (MET) Agonist Transiently Delays the Disease Progression in an Amyotrophic Lateral Sclerosis Mouse Model by Promoting Neuronal Survival and Dampening the Immune Dysregulation.
    Vallarola A; Tortarolo M; De Gioia R; Iamele L; de Jonge H; de Nola G; Bovio E; Pasetto L; Bonetto V; Freschi M; Bendotti C; Gherardi E
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.